Teva Pharmaceutical Industries (TEVA) News Today $16.18 +0.08 (+0.48%) Closing price 03/24/2025 03:59 PM EasternExtended Trading$16.22 +0.04 (+0.26%) As of 08:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Sound Shore Management Inc. CT's 3rd Largest PositionSound Shore Management Inc. CT reduced its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 20.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,772,712 shares ofMarch 25 at 6:39 AM | marketbeat.comEmerald Advisers LLC Has $1.10 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Emerald Advisers LLC cut its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 41.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,750 shares of the company's stock after selling 35,809 shares durinMarch 25 at 5:45 AM | marketbeat.comKLP Kapitalforvaltning AS Takes $8.97 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)KLP Kapitalforvaltning AS purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 407,059 shares of the company's stock, valuedMarch 25 at 4:48 AM | marketbeat.comBillionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround StocksMarch 24 at 5:06 AM | fool.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Boston PartnersBoston Partners trimmed its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 83.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,415 shares ofMarch 24 at 4:14 AM | marketbeat.comTeacher Retirement System of Texas Raises Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Teacher Retirement System of Texas grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 38.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 662,797 shares of the company's stock after purchasing an additional 1March 23 at 4:57 AM | marketbeat.comBlueshift Asset Management LLC Cuts Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Blueshift Asset Management LLC reduced its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 55.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 18,368 shares of the company's stock after selling 22,718 shares during the quartMarch 22 at 5:29 AM | marketbeat.comiA Global Asset Management Inc. Sells 85,772 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)iA Global Asset Management Inc. lessened its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 19.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 355,119 shares of the company's stock after selling 85,7March 22 at 5:20 AM | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Upgraded at StockNews.comMarch 22 at 2:21 AM | americanbankingnews.com2TEVA : Teva Pharmaceutical Indus's Options: A Look at What the Big Money is...March 21, 2025 | benzinga.comVinva Investment Management Ltd Reduces Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Vinva Investment Management Ltd trimmed its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 14.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 187,064 shares of the company's stock after selling 30,656 shares durinMarch 21, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Upgraded to Buy at StockNews.comStockNews.com raised Teva Pharmaceutical Industries from a "hold" rating to a "buy" rating in a report on Wednesday.March 20, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd Investor Day TranscriptMarch 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd at Bank of America Healthcare Conference TranscriptMarch 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd at Goldman Sachs Global Healthcare Conference TranscriptMarch 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd at Bank of America Global Healthcare Conference TranscriptMarch 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd to Discuss The Duvakitug (Anti-TL1A) Positive Phase 2b ...March 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptMarch 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd to Discuss New Data Presented for Duvakitug (Anti-TL1A) ...March 20, 2025 | gurufocus.comTeva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference TranscriptMarch 20, 2025 | gurufocus.comNatixis Advisors LLC Buys 335,667 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Natixis Advisors LLC increased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 198.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 504,534 shares of the company's stock afMarch 20, 2025 | marketbeat.comHighTower Advisors LLC Grows Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)HighTower Advisors LLC boosted its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 32.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 196,657 shares of the company's stock after acquiring aMarch 20, 2025 | marketbeat.comHere Are Billionaire Stanley Druckenmiller's 5 Biggest Stock HoldingsMarch 19, 2025 | fool.comCharles Schwab Investment Management Inc. Raises Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Charles Schwab Investment Management Inc. grew its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 14.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,028,924 shareMarch 19, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug ApplicationMarch 18, 2025 | finance.yahoo.comTeva Pharmaceutical Stock Scores RS Rating UpgradeMarch 18, 2025 | msn.comHIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMRMarch 18, 2025 | finance.yahoo.comWilliam Blair Investment Management LLC Reduces Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)William Blair Investment Management LLC lowered its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 2.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,241,547 shares of the company's stock aMarch 18, 2025 | marketbeat.comQuantbot Technologies LP Takes Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Quantbot Technologies LP purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 226,274 shaMarch 16, 2025 | marketbeat.comPicton Mahoney Asset Management Acquires 213,041 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Picton Mahoney Asset Management boosted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 50.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 633,149 shares of the companMarch 16, 2025 | marketbeat.comSwiss National Bank Sells 215,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Swiss National Bank cut its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,127,900 shares of the company's stock after sellinMarch 16, 2025 | marketbeat.comKing Wealth Management Group Sells 83,602 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)King Wealth Management Group reduced its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 85.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,500 shares of the comMarch 15, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Stake Lifted by Skandinaviska Enskilda Banken AB publSkandinaviska Enskilda Banken AB publ increased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 13.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,432,374 sharMarch 15, 2025 | marketbeat.comAmundi Lowers Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Amundi lessened its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 12.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 572,912 shares of the company's stock after selling 80,March 15, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Stock Position Raised by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank lifted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 475,606 shares of the company's stock afterMarch 14, 2025 | marketbeat.comKLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay AreaMarch 13, 2025 | tmcnet.comAchmea Investment Management B.V. Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Achmea Investment Management B.V. grew its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 49.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 860,894 shares of the company'sMarch 13, 2025 | marketbeat.comRaymond James Financial Inc. Invests $38.91 Million in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Raymond James Financial Inc. bought a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,765,593 shares of thMarch 13, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Leerink's 2025 Global Healthcare Conference (Transcript)March 12, 2025 | seekingalpha.comTeva Pharmaceutical Industries (NYSE:TEVA) Trading Up 5.1% - Still a Buy?Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Up 5.1% - Should You Buy?March 12, 2025 | marketbeat.comProsperity Wealth Management Inc. Invests $505,000 in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Prosperity Wealth Management Inc. bought a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 22,900 shares of the company's stock, valued at approximately $March 12, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)March 11, 2025 | seekingalpha.comTaika Capital LP Takes $771,000 Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Taika Capital LP bought a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 35,000 shares of the company's stock, valued at approximaMarch 10, 2025 | marketbeat.comOppenheimer & Co. Inc. Sells 22,124 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Oppenheimer & Co. Inc. trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 68.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,278 shares of the company's stock after sMarch 10, 2025 | marketbeat.comGenerali Investments CEE investicni spolecnost a.s. Purchases New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Generali Investments CEE investicni spolecnost a.s. purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 20,400 shares of the comMarch 9, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Stock Rating Lowered by StockNews.comStockNews.com lowered shares of Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating in a report on Friday.March 8, 2025 | marketbeat.comEquities Analysts Offer Predictions for TEVA FY2025 EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Stock analysts at Zacks Research lowered their FY2025 earnings estimates for Teva Pharmaceutical Industries in a report issued on Wednesday, March 5th. Zacks Research analyst R. Department now anticipates that the company will posMarch 8, 2025 | marketbeat.comVictory Capital Management Inc. Raises Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Victory Capital Management Inc. boosted its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 56.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,023,474 shares of the company'March 8, 2025 | marketbeat.comBank of New York Mellon Corp Increases Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Bank of New York Mellon Corp grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,621,344 shares of the company's stock after buying an additional 6March 8, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Sees Significant Increase in Short InterestTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 26,660,000 shares, a growth of 19.2% from the January 31st total of 22,360,000 shares. Based on an average daily volume of 11,930,000 shares, the days-to-cover ratio is presently 2.2 days.March 7, 2025 | marketbeat.com Remove Ads Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.700.63▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼2710▲TEVA Articles Average Week Remove Ads Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News ARGX News ONC News BNTX News SMMT News ITCI News MRNA News GMAB News RDY News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TEVA Stock Free TEVA Stock Alerts